Metronidazole (MTZ) is a first-line drug for the treatment of human infections caused by anaerobic bacteria. Although most Clostridium perfringens isolates are susceptible to metronidazole, a number of strains with decreased susceptibility have been obtained in clinical and environmental surveys. However, little is known yet about the toxinotype and genetic diversity of metronidazole-resistant C. perfringens strains. We tested for susceptibility to metronidazole and assessed the toxigenic status and amplified fragment length polymorphism (AFLP) diversity of a collection of 80 C. perfringens isolates of animal origin. In vitro susceptibility testing by the standard agar dilution technique revealed that 22 isolates (27.5% of total) were susceptible to metronidazole, 54 (67.5%) intermediate susceptible, and four (5%) resistant. All isolates belonged to toxinotype A, and two, 41 and 17, of them yielded a positive PCR result for presence of the gene encoding for enterotoxin (cpe), the consensus form of β2 toxin (cpb2) and the atypical form of β2 toxin, respectively. AFLP fingerprinting classified isolates into 65 genotypes indicating a high molecular diversity among isolates in this study, and this diversity was reflected among isolates from each susceptibility category. In conclusion, the results of this study revealed extensive genetic diversity among C. perfringens type A isolates regardless of their susceptibility to metronidazole.
Get full access to this article
View all access options for this article.
References
1.
SongerJ.G., and UzalF.A.. 2005. Clostridial enteric infections in pigs. J. Vet. Diagn. Invest. 17:528–536.
2.
UzalF.A., and SongerJ.G.. 2008. Diagnosis of Clostridium perfringens intestinal infections in sheep and goats. J. Vet. Diagn. Invest. 20:253–265.
SilvaR., and FO.S.. LobatoC.F.. 2015. Clostridium perfringens: a review of enteric diseases in dogs, cats and wild animals. Anaerobe. 33:14–17.
5.
LeuteneggerC.M.2016. Clostridium perfringens and its arsenal of toxins. Vet. Rec. 178:213–214.
6.
BrynestadS., and GranumP.E.. 2002. Clostridium perfringens and foodborne infections. Int. J. Food Microbiol. 74:195–202.
7.
BennettS.D., WalshK.A., and GouldL.H.. 2013. Foodborne disease outbreaks caused by Bacillus cereus, Clostridium perfringens, and Staphylococcus aureus−United States, 1998–2008. Clin. Infect. Dis. 57:425–433.
8.
GrassJ.E., GouldL.H., and MahonB.E.. 2013. Epidemiology of foodborne disease outbreaks caused by Clostridium perfringens, United States, 1998–2010. Foodborne Pathog. Dis. 10:131–136.
9.
UzalF.A., FreedmanJ.C., ShresthaA., TheoretJ.R., GarciaJ., AwadM.M., AdamsV., MooreR.J., RoodJ.I., and McClaneB.A.. 2014. Towards an understanding of the role of Clostridium perfringens toxins in human and animal disease. Future Microbiol. 9:361–377.
10.
DhandA., and SnydmanD.R.. 2009. Mechanism of resistance in metronidazole. In MayersD.L. (ed.), Antimicrobial drug resistance, vol. 1: mechanisms of drug resistance. Humana Press, New York, NY, pp. 223–227.
11.
NagyE., and SchuetzA.. 2015. Is there a need for the antibiotic susceptibility testing of anaerobic bacteria?Anaerobe. 31:2–3.
12.
LöfmarkS., EdlundC., and NordC.E.. 2010. Metronidazole is still the drug of choice for treatment of anaerobic infections. Clin. Infect. Dis. 50,(Suppl.1)::S16–S23.
13.
PapichG.M.2016. Metronidazole. In PapichG.M. (ed.), Saunders handbook of veterinary drugs: small and large animal, 4th ed. Saunders, St. Louis, MO, pp. 524–526.
14.
JarradA.M., DebnathA., MiyamotoY., HansfordK.A., PelingonR., ButlerM.S., BainsT., KaroliT., BlaskovichM.A., EckmannL., and CooperM.A.. 2016. Nitroimidazole carboxamides as antiparasitic agents targeting Giardia lamblia, Entamoeba histolytica and Trichomonas vaginalis. Eur. J. Med. Chem. 120:353–362.
15.
RobertsS.A., ShoreK.P., PaviourS.D., HollandD., and MorrisA.J.. 2006. Antimicrobial susceptibility of anaerobic bacteria in New Zealand: 1999–2003. J. Antimicrob. Chemother. 57:992–998.
16.
LawhonS.D., TaylorA., and FajtV.R.. 2013. Frequency of resistance in obligate anaerobic bacteria isolated from dogs, cats, and horses to antimicrobial agents. J. Clin. Microbiol. 51:3804–3810.
17.
Marchand-AustinA., RawteP., ToyeB., JamiesonF.B., FarrellD.J., and PatelS.N.. 2014. Antimicrobial susceptibility of clinical isolates of anaerobic bacteria in Ontario, 2010–2011. Anaerobe. 28:120–125.
18.
SilvaR.O., D'EliaM.L., Tostes TeixeiraE.P., PereiraP.L., de Magalhães SoaresD.F., CavalcantiÁ.R., KocuvanA., RupnikM., SantosA.L., JuniorC.A., and LobatoF.C.. 2014. Clostridium difficile and Clostridium perfringens from wild carnivore species in Brazil. Anaerobe. 28:207–211.
19.
WyboI., Van den BosscheD., SoetensO., VekensE., VandoorslaerK., ClaeysG., GlupczynskiY., IevenM., MelinP., NonhoffC., Rodriguez-VillalobosH., VerhaegenJ., and PiérardD.. 2014. Fourth Belgian multicentre survey of antibiotic susceptibility of anaerobic bacteria. J. Antimicrob. Chemother. 69:155–161.
20.
MarksS.L., and KatherE.J.. 2003. Antimicrobial susceptibilities of canine Clostridium difficile and Clostridium perfringens isolates to commonly utilized antimicrobial drugs. Vet. Microbiol. 94:39–45.
21.
TansuphasiriU., MatraW., and SangsukL.. 2005. Antimicrobial resistance among Clostridium perfringens isolated from various sources in Thailand. Southeast Asian J. Trop. Med. Public Health 36:954–961.
22.
SlavićD., BoerlinP., FabriM., KlotinsK.C., ZoethoutJ.K., WeirP.E., and BatemanD.. 2011. Antimicrobial susceptibility of Clostridium perfringens isolates of bovine, chicken, porcine, and turkey origin from Ontario. Can. J. Vet. Res. 75:89–97.
23.
Álvarez-PérezS., BlancoJ.L., PeláezT., Martínez-NevadoE., and GarcíaM.E.. 2016. Water sources in a zoological park harbor genetically diverse strains of Clostridium perfringens type A with decreased susceptibility to metronidazole. Microb. Ecol. 72:783–790.
24.
Clinical and Laboratory Standards Institute (CLSI). 2012. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; approved standard–8th ed. CLSI M11-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
25.
JostB.H., BillingtonS.J., TrinhH.T., BueschelD.M., and SongerJ.G.. 2005. Atypical cpb2 genes, encoding beta2-toxin in Clostridium perfringens isolates of nonporcine origin. Infect. Immun. 73:652–656.
26.
ExcoffierL., SmouseP.E., and QuattroJ.M.. 1992. Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics. 131:479–491.
27.
PeakallR., and SmouseP.E.. 2012. GenAlEx 6.5: genetic analysis in Excel. Population genetic software for teaching and research-an update. Bioinformatics. 28:2537–2539.
28.
HammerØ., HarperD.A.T., and RyanP.D.. 2001. PAST: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontol. Electron. 4:1–9.
29.
Álvarez-PérezS., BlancoJ.L., HarmanusC., KuijperE., and GarcíaM.E.. 2017. Subtyping and antimicrobial susceptibility of Clostridium difficile PCR ribotype 078/126 isolates of human and animal origin. Vet. Microbiol. 199:15–22.
30.
KillgoreG., ThompsonA., JohnsonS., BrazierJ., KuijperE., PepinJ., FrostE.H., SavelkoulP., NicholsonB., van den BergR.J., KatoH., SambolS.P., ZukowskiW., WoodsC., LimbagoB., GerdingD.N., and McDonaldL.C.. 2008. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J. Clin. Microbiol. 46:431–437.
31.
KnetschC.W., HensgensM.P., HarmanusC., van der BijlM.W., SavelkoulP.H., KuijperE.J., CorverJ., and van LeeuwenH.C.. 2011. Genetic markers for Clostridium difficile lineages linked to hypervirulence. Microbiology. 157:3113–3123.
32.
MaslankaS.E., KerrJ.G., WilliamsG., BarbareeJ.M., CarsonL.A., MillerJ.M., and SwaminathanB.. 1999. Molecular subtyping of Clostridium perfringens by pulsed-field gel electrophoresis to facilitate food-borne-disease outbreak investigations. J. Clin. Microbiol. 37:2209–2214.
33.
LukinmaaS., TakkunenE., and SiitonenA.. 2002. Molecular epidemiology of Clostridium perfringens related to food-borne outbreaks of disease in Finland from 1984 to 1999. Appl. Environ. Microbiol. 68:3744–3749.
34.
MonmaC., HatakeyamaK., ObataH., YokoyamaK., KonishiN., ItohT., and KaiA.. 2015. Four foodborne disease outbreaks caused by a new type of enterotoxin-producing Clostridium perfringens. J. Clin. Microbiol. 53:859–867.
35.
ChalmersG., BruceH.L., HunterD.B., ParreiraV.R., KulkarniR.R., JiangY.F., PrescottJ.F., and BoerlinP.. 2008. Multilocus sequence typing analysis of Clostridium perfringens isolates from necrotic enteritis outbreaks in broiler chicken populations. J. Clin. Microbiol. 46:3957–3964.
36.
JohanssonA., AspánA., KaldhusdalM., and EngströmB.E.. 2010. Genetic diversity and prevalence of netB in Clostridium perfringens isolated from a broiler flock affected by mild necrotic enteritis. Vet. Microbiol. 144:87–92.
37.
LyhsU., Perko-MäkeläP., KallioH., BrockmannA., HeinikainenS., TuuriH., and PedersenK.. 2013. Characterization of Clostridium perfringens isolates from healthy turkeys and from turkeys with necrotic enteritis. Poult. Sci. 92:1750–1757.
38.
ParkJ.Y., KimS., OhJ.Y., KimH.R., JangI., LeeH.S., and KwonY.K.. 2015. Characterization of Clostridium perfringens isolates obtained from 2010 to 2012 from chickens with necrotic enteritis in Korea. Poult. Sci. 94:1158–1164.
39.
JohanssonA., AspanA., BaggeE., BåverudV., EngströmB.E., and JohanssonK.E.. 2006. Genetic diversity of Clostridium perfringens type A isolates from animals, food poisoning outbreaks and sludge. BMC Microbiol. 6:47.
40.
CharleboisA., JalbertL.A., HarelJ., MassonL., and ArchambaultM.. 2012. Characterization of genes encoding for acquired bacitracin resistance in Clostridium perfringens. PLoS One. 7:e44449.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
